Lorviqua (lorlatinib) 100 mg film-coated tablets, 30 tablets — original (Pfizer) Lorlatinib for the treatment of metastatic non-small cell lung cancer (NSCLC) Targeted cancer therapy. Drug delivery from Europe. Order by calling +380996042415, Viber, or WhatsApp.
Delivery methods
- EMC post
Delivery time
- 7-10 days
Payment methods
- Payment to Revolut card
Indications for Use
Lorlatinib is indicated for the treatment of patients with:
- anaplastic lymphoma kinase (ALK);
- metastatic non-small cell lung cancer (NSCLC) that has progressed on treatment with crizotinib, alectinib, or ceritinib (with metastases).
- Trade Name:Lorviqua
- Chemical Name:Lorlatinib
- Dosage:100 mg
- Quantity:30
- Form of Issue:Tablets
No reviews yet
